Dosing
Patient Resources - Scemblix
MPN10 - Symptoomzoeker
Download Dutch document .field-name-field-np4-expiry-date {display:none;} To receive by post, click on the "Add to card" button belowMPN10 - Connaissez votre score
Download French document .field-name-field-np4-expiry-date {display:none;} To receive by post, click on the "Add to card" button belowIndication - Kesimpta
Kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features 1
Both newly diagnosed patients and patients switching from...
Twitter Linkedin Facebook Pinterest Google plusEfficacy - Kesimpta
Safety Profile - Kesimpta
Reimbursement / E-health - Kesimpta
Kesimpta ® is reimbursed in Belgium for adult patients with clinically proven relapsing multiple sclerosis (RMS) who meet the following criteria* :
The patient has a fast evolving, serious form of relapsing multiple sclerosis (RMS...
Twitter Linkedin Facebook Pinterest Google plusMechanism of Action
Kesimpta ® is a targeted and precisely delivered B-cell therapy 1,5B-cells play a central role in the pathogenesis of MS 4
KESIMPTA ® (ofatumumab) is a fully human anti...
Twitter Linkedin Facebook Pinterest Google plus
